Literature DB >> 8777847

Autoantibodies in black South Africans with systemic lupus erythematosus: spectrum and clinical associations.

M Tikly1, S Burgin, P Mohanlal, A Bellingan, J George.   

Abstract

The clinical features and autoantibody profile of 111 black South Africans (103 females and 8 males) with systemic lupus erythematosus was retrospectively analysed. The mean age of the patients was 35.1 years and mean duration of disease 3.5 years. The commonest clinical and laboratory features noted were arthritis (62.2%), hypocomplementaemia (61.2%), haematological abnormalities (60.5%) and malar rash (55%). The serological abnormalities included antinuclear antibodies (98.2%), anti-dsDNA (66.2%), anti-Sm (44.2%), anti-RNP (65.5%), anti-Ro (60.5%), anti-La (28.4%) and rheumatoid factor (10.1%). Positive clinicoserological associations observed included: combination of anti-dsDNA antibodies and low C4 levels with renal disease; anti-dsDNA antibodies with cutaneous vasculitis; anti-Sm antibodies with psychosis; anti-RNP antibodies with Raynaud's phenomenon; anti-Ro antibodies with renal disease, psychosis and malar rash. Anti-La antibodies showed a weak negative association with serositis and Raynaud's phenomenon. Most of these clinical correlates are consistent with past studies. The high frequency of anti-Sm and anti-RNP antibodies is similar to the observations in African-Americans and Afro-Caribbeans.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8777847     DOI: 10.1007/bf02230331

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  27 in total

Review 1.  Polymyositis and dermatomyositis (first of two parts).

Authors:  A Bohan; J B Peter
Journal:  N Engl J Med       Date:  1975-02-13       Impact factor: 91.245

2.  Systemic lupus erythematosus in Black and Indian patients in Natal.

Authors:  Y K Seedat; D Pudifin
Journal:  S Afr Med J       Date:  1977-03-12

Review 3.  Ethnic and geographic perspectives in SLE.

Authors:  G Citera; W A Wilson
Journal:  Lupus       Date:  1993-12       Impact factor: 2.911

4.  Photosensitivity and anti-Ro (SS-A) antibodies in black patients with systemic lupus erythematosus (SLE).

Authors:  P G Sutej; A J Gear; R C Morrison; M Tikly; M de Beer; L Dos Santos; R Sher
Journal:  Br J Rheumatol       Date:  1989-08

5.  Systemic lupus erythematosus in the community. Incidence, prevalence, outcome, and first symptoms; the high prevalence in black women.

Authors:  W J Fessel
Journal:  Arch Intern Med       Date:  1974-12

6.  Autoimmune disease and parasitic infections in Nigerians.

Authors:  B M Greenwood
Journal:  Lancet       Date:  1968-08-17       Impact factor: 79.321

7.  Serologic studies in patients with systemic lupus erythematosus and central nervous system dysfunction.

Authors:  J B Winfield; C M Brunner; D Koffler
Journal:  Arthritis Rheum       Date:  1978-04

Review 8.  The molecular basis of the SSA/Ro antigens and the clinical significance of their autoantibodies.

Authors:  E Ben-Chetrit
Journal:  Br J Rheumatol       Date:  1993-05

9.  Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus.

Authors:  R Cervera; M A Khamashta; J Font; G D Sebastiani; A Gil; P Lavilla; I Doménech; A O Aydintug; A Jedryka-Góral; E de Ramón
Journal:  Medicine (Baltimore)       Date:  1993-03       Impact factor: 1.889

10.  Clinical and serological differences between systemic lupus erythematosus patients with antibodies to Ro versus patients with antibodies to Ro and La.

Authors:  C A Wasicek; M Reichlin
Journal:  J Clin Invest       Date:  1982-04       Impact factor: 14.808

View more
  6 in total

1.  HLA-DR gene frequencies in a Zaïrean population with particular reference to rheumatic diseases.

Authors:  K Mbayo; J M Mbuyi-Muamba; L Hallé; D Salmon; C Martageix; F Castellano; C Kaplan; Z Lurhuma
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

2.  Prevalence of oral manifestations in patients with lupus erythematosus in a sample of the Egyptian population: a hospital based cross-sectional study.

Authors:  Hager Moustafa Saeed; Eman Mohammad Amr; Alshaimaa Rezk Lotfy Rezk; Wesam Abd Elmoneim
Journal:  F1000Res       Date:  2021-09-27

3.  Scleroderma (systemic sclerosis) among Nigerians.

Authors:  O O Adelowo; S Oguntona
Journal:  Clin Rheumatol       Date:  2009-05-13       Impact factor: 2.980

Review 4.  New insights into the role of antinuclear antibodies in systemic lupus erythematosus.

Authors:  David S Pisetsky; Peter E Lipsky
Journal:  Nat Rev Rheumatol       Date:  2020-09-03       Impact factor: 20.543

5.  Serum nitrated nucleosome levels in patients with systemic lupus erythematosus: a retrospective longitudinal cohort study.

Authors:  Sara Croca; Paul Bassett; Charis Pericleous; Karim Fouad Alber; David Latchman; David Isenberg; Ian Giles; Anisur Rahman; Yiannis Ioannou
Journal:  Arthritis Res Ther       Date:  2014-02-07       Impact factor: 5.156

6.  Sudanese and Swedish patients with systemic lupus erythematosus: immunological and clinical comparisons.

Authors:  Sahwa Elbagir; Amir I Elshafie; Elnour M Elagib; NasrEldeen A Mohammed; Mawahib I E Aledrissy; Azita Sohrabian; Musa A M Nur; Elisabet Svenungsson; Iva Gunnarsson; Johan Rönnelid
Journal:  Rheumatology (Oxford)       Date:  2020-05-01       Impact factor: 7.580

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.